Colin Sandercock

Colin Sandercock

Corporate Officer/Principal presso CUE BIOPHARMA, INC.

Patrimonio netto: 14 572 $ in data 31/08/2026

69 anni
Commercial Services
Consumer Services
Health Technology

Profilo

Colin G.
Sandercock
is Senior Vice President-Intellectual Property at Cue Biopharma, Inc. since 2026, with employment at the firm starting in 2017.
Former positions include Partner at Ashurst Perkins Coie US LLP from 2009 to 2017, Co-Chairman-Life Science Practice Group at Proskauer Rose LLP from 2006 to 2009, Co-Chairman-Intellectual Property Practice Group at Heller Ehrman LLP from 2000 to 2006, and Chairman-Chemical Practice Group at Foley & Lardner LLP from 1990 to 2000.
Education includes graduate degrees from the University of Pennsylvania in 1980 and The Catholic University of America in 1984, and an undergraduate degree from Moravian College in 1978.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
05/05/2026 571 ( 0,01% ) 14 572 $ 31/08/2026

Posizioni attive di Colin Sandercock

SocietàPosizioneInizio
CUE BIOPHARMA, INC. Corporate Officer/Principal 01/06/2026

Precedenti posizioni note di Colin Sandercock

SocietàPosizioneFine
Corporate Officer/Principal 01/11/2017
Corporate Officer/Principal 01/07/2009
Corporate Officer/Principal 01/01/2006
Corporate Officer/Principal 01/01/2000
Vedi nel dettaglio l'esperienza di Colin Sandercock

Formazione di Colin Sandercock

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

64

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

  1. Mercati
  2. Insiders
  3. Colin Sandercock